摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

N-[(2S,5S,6S)-2-(cyanomethylsulfanyl)-4-[(2R,5R,6S)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2S,5S,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-2-yl]oxy-6-(hydroxymethyl)-5-[(2S,3S,5S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-3-yl]acetamide

中文名称
——
中文别名
——
英文名称
N-[(2S,5S,6S)-2-(cyanomethylsulfanyl)-4-[(2R,5R,6S)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2S,5S,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-2-yl]oxy-6-(hydroxymethyl)-5-[(2S,3S,5S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-3-yl]acetamide
英文别名
——
N-[(2S,5S,6S)-2-(cyanomethylsulfanyl)-4-[(2R,5R,6S)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2S,5S,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-2-yl]oxy-6-(hydroxymethyl)-5-[(2S,3S,5S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-3-yl]acetamide化学式
CAS
——
化学式
C28H46N2O18S
mdl
——
分子量
730.7
InChiKey
FLYSXXZWNHTGCP-FXYXXZQMSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    -5.8
  • 重原子数:
    49
  • 可旋转键数:
    11
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.93
  • 拓扑面积:
    345
  • 氢给体数:
    11
  • 氢受体数:
    20

文献信息

  • [EN] INFLAMMATION IMAGING AND THERAPY<br/>[FR] IMAGERIE ET THÉRAPIE D'UNE INFLAMMATION
    申请人:ISIS INNOVATION
    公开号:WO2014027203A1
    公开(公告)日:2014-02-20
    An imaging agent comprising a conjugate of an oligosaccharide moiety with an imaging moiety. The oligosaccharide is Lewis A or Lewis B or a mimetic thereof, or a pharmaceutically acceptable salt or PEGylated form of Lewis A or Lewis B or its mimetics. Lewis A and Lewis B and its mimetics are also provided for use in the therapeutic treatment of inflammatory diseases, autoimmune diseases and cancer.
    一种成像剂,包括寡糖基团与成像基团的结合物。该寡糖为Lewis A或Lewis B或其模拟物,或Lewis A或Lewis B或其模拟物的药用盐或PEG化形式。Lewis A和Lewis B及其模拟物还可用于治疗炎症性疾病、自身免疫疾病和癌症。
  • INFLAMMATION IMAGING AND THERAPY
    申请人:Isis Innovation Limited
    公开号:US20150231281A1
    公开(公告)日:2015-08-20
    An imaging agent comprising a conjugate of an oligosaccharide moiety with an imaging moiety. The oligosaccharide is Lewis A or Lewis B or a mimetic thereof, or a pharmaceutically acceptable salt or PEGylated form of Lewis A or Lewis B or its mimetics. Lewis A and Lewis B and its mimetics are also provided for use in the therapeutic treatment of inflammatory diseases, autoimmune diseases and cancer.
    一种成像剂,包括具有寡糖基团和成像基团的共轭物。寡糖是Lewis A或Lewis B或其类似体,或者是Lewis A或Lewis B或其类似体的药用盐或PEG化形式。还提供了Lewis A和Lewis B及其类似体,用于治疗炎症性疾病、自身免疫性疾病和癌症。
查看更多